Literature DB >> 32512635

Uncovering psychobehavioural implications of SARS-CoV-2 infection in Iran.

Li Ping Wong1, Haridah Alias1, Mahmoud Danaee1, Masood Ziaee2, Farshid Abedi2, Arash Ziaee3, Samira Mohajer4,5, Reza HajiAliBeigloo6, Mohammad Namazi Nia7, Fateme Jamei8, Seyed Reza Mazlom9.   

Abstract

Iran is the country in Western Asia most impacted by the COVID-19 outbreak. A survey was conducted among the general public in Iran aimed at investigating psychobehavioural issues related to the COVID-19 outbreak, namely (a) barriers to preventive measures against SARS-CoV-2 infection; (b) negative emotions towards SARS-CoV-2 infection; and (c) anxiety levels among the general public in Iran. A cross-sectional, web-based survey using an online questionnaire was carried out between 16 March and 1 April 2020. The six-item version of the State-Trait Anxiety Inventory (STAI-6) was used to assess anxiety levels. A total of 1,789 complete responses were received. Nearly 60% reported having difficulty in wearing a face mask to protect against SARS-CoV-2 infection. The mean and standard deviation (SD) for the total prevention barrier score was 35.8 (SD ± 7.1; range 18-68) out of a possible score of 72. Male respondents [odds ratio (OR) = 1.25; 95% confidence interval (CI) 1.03-1.51] and respondents who perceived their health status as poor/fair (OR = 1.49; 95% CI 1.31-1.82) were predictors of high prevention barriers. Negative emotions such as fear (74.6%) followed by depression (43.4%) and stigma (23.0%) associated with SARS-CoV-2 infection were reported. Respondents who perceived their health as poor/fair (OR = 2.19; 95% CI 1.57-3.04) reported a higher likelihood of having higher negative emotions. Findings on anxiety level revealed 68.0% (95% CI 65.8-70.1) reported moderate to severe anxiety. Respondents who perceived their health as poor/fair (OR = 3.46; 95% CI 12.22-5.40) and who were females (OR = 1.91; 95% CI 1.55-2.36) were predictors of moderate to severe anxiety. In conclusion, psychobehavioural interventions are needed to facilitate management and control of the COVID-19 outbreak.
© 2020 Blackwell Verlag GmbH.

Entities:  

Keywords:  COVID-19; Iran; SARS-CoV-2; anxiety; psychobehavioural

Mesh:

Year:  2020        PMID: 32512635     DOI: 10.1111/tbed.13662

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  5 in total

1.  Health Anxiety Predicts Postponing or Cancelling Routine Medical Health Care Appointments among Women in Perinatal Stage during the Covid-19 Lockdown.

Authors:  Mehran Shayganfard; Fateme Mahdavi; Mohammad Haghighi; Dena Sadeghi Bahmani; Serge Brand
Journal:  Int J Environ Res Public Health       Date:  2020-11-09       Impact factor: 3.390

2.  Psychological impact of COVID-19 on health-care workers: A multicenter cross-sectional study.

Authors:  Mohammad Mousavi; Najmeh Ahmadi; Hooria Seyedhosseini Ghaheh; Atefeh Vaezi; Shaghayegh Haghjooy Javanmard
Journal:  J Res Med Sci       Date:  2021-09-30       Impact factor: 1.852

3.  The effects of family-centered empowerment model on depression, anxiety, and stress of the family caregivers of patients with COVID-19: a randomized clinical trial.

Authors:  Mohammad Namazi Nia; Samira Mohajer; Nasser Bagheri; Tahere Sarboozi-Hoseinabadi
Journal:  BMC Prim Care       Date:  2022-07-26

Review 4.  Prevalence of anxiety during the COVID-19 pandemic: A systematic review and meta-analysis of over 2 million people.

Authors:  Felipe Mendes Delpino; Carine Nascimento da Silva; Jeferson Santos Jerônimo; Eliete Stark Mulling; Larissa Leal da Cunha; Marina Krause Weymar; Ricardo Alt; Eduardo L Caputo; Natan Feter
Journal:  J Affect Disord       Date:  2022-09-10       Impact factor: 6.533

5.  Sources of Sleep Disturbances and Psychological Strain for Hospital Staff Working during the COVID-19 Pandemic.

Authors:  Nasrin Abdoli; Vahid Farnia; Somayeh Jahangiri; Farnaz Radmehr; Mostafa Alikhani; Pegah Abdoli; Omran Davarinejad; Kenneth M Dürsteler; Annette Beatrix Brühl; Dena Sadeghi-Bahmani; Serge Brand
Journal:  Int J Environ Res Public Health       Date:  2021-06-10       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.